GO:0050262 ribosylnicotinamide kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050262 (ribosylnicotinamide kinase activity) catalyzes the phosphorylation of beta-nicotinamide D-riboside (NR) to beta-nicotinamide D-ribonucleotide (NMN) using ATP.
• The enzyme is conserved from bacteria to mammals; in bacteria it is part of the NadR protein, while in mammals the NRK1 and NRK2 kinases carry out this activity.
• NRK1 controls the intracellular metabolism of both nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) in mammalian cells.
• This activity is a rate-limiting step in the NAD+ salvage pathway, linking dietary NR to cellular NAD+ pools.
• Boosting NAD+ via NR supplementation has shown protective effects in models of ischemic brain injury, Alzheimer's disease, and myocardial infarction.
• Dysregulation of this pathway is implicated in neuroinflammation, cellular senescence, and metabolic stress, making it a target for therapeutic intervention.
Description
Ribosylnicotinamide kinase activity (GO:0050262) is a molecular function that enables the transfer of a phosphate group from ATP to beta-nicotinamide D-riboside (NR), yielding beta-nicotinamide D-ribonucleotide (NMN) and ADP. This reaction is a critical step in the NAD+ salvage pathway, allowing cells to recycle nicotinamide riboside into the central redox cofactor NAD+. The enzyme responsible was first identified in bacteria as part of the NadR protein, which couples ribosylnicotinamide kinase activity with other NAD biosynthetic functions. In mammals, the nicotinamide riboside kinases NRK1 and NRK2 perform this phosphorylation, with NRK1 being the predominant isoform in most tissues. Researchers study GO:0050262 because it directly influences NAD+ homeostasis, which is essential for energy metabolism, DNA repair, and cell survival. The activity is highly conserved across evolution, underscoring its fundamental role in cellular physiology. In recent years, the therapeutic potential of activating this pathway has been explored in neurodegeneration, cardiovascular disease, and metabolic disorders. Understanding the regulation and kinetics of ribosylnicotinamide kinase activity is therefore central to developing interventions that modulate NAD+ levels. This article provides a comprehensive overview of the molecular mechanism, key genes, disease associations, and experimental models used to study ribosylnicotinamide kinase activity. It is intended for researchers seeking to investigate this pathway using CRISPR-based tools and other advanced methodologies.
ribosylnicotinamide kinase activity At A Glance
| GO ID | GO:0050262 |
|---|---|
| GO term | ribosylnicotinamide kinase activity |
| Ontology | molecular_function |
| Synonym | ATP:N-ribosylnicotinamide 5'-phosphotransferase activity; nicotinamide riboside kinase activity; ribosylnicotinamide kinase (phosphorylating) |
| Major function | Phosphorylation of nicotinamide riboside to nicotinamide mononucleotide in NAD+ salvage |
| Reaction | beta-nicotinamide D-riboside + ATP = beta-nicotinamide D-ribonucleotide + ADP + H+ |
| Cofactors | ATP (as phosphate donor); Mg2+ likely required |
| Organisms | Bacteria (NadR), mammals (NRK1, NRK2) |
What Is GO:0050262?
Ribosylnicotinamide kinase activity (GO:0050262) is defined as the catalysis of the reaction: beta-nicotinamide D-riboside + ATP = beta-nicotinamide D-ribonucleotide + ADP + H+. In simpler terms, it is the enzyme activity that adds a phosphate group to nicotinamide riboside, converting it to nicotinamide mononucleotide, a direct precursor of NAD+.
Why Is ribosylnicotinamide kinase activity Important in Cell Biology?
Ribosylnicotinamide kinase activity is a key control point in NAD+ biosynthesis, directly impacting cellular energy metabolism, redox balance, and stress responses. By converting nicotinamide riboside to NMN, it determines the availability of NAD+ precursors and thus influences processes such as mitochondrial function, DNA repair, and inflammation. Its evolutionary conservation from bacteria to humans highlights its essential role in maintaining NAD+ pools. Consequently, this activity is a promising target for therapeutic strategies aimed at boosting NAD+ to combat aging-related and metabolic diseases.
• Regulates NAD+ salvage pathway, a central node in cellular metabolism.
• NRK1, the main mammalian enzyme with this activity, controls NMN and NR metabolism.
• NAD+ supplementation via NR reduces hippocampal damage and preserves cognitive function after ischemic injury.
• Modulating this pathway reduces neuroinflammation and senescence in Alzheimer's disease models.
• NR supplementation improves survival and cardiac outcomes post-myocardial infarction.
• Bacterial NadR integrates ribosylnicotinamide kinase activity with transcriptional regulation of NAD biosynthesis.
• The activity is linked to suppression of cytokine production in keratinocytes via p38 pathway.
• Mitochondrial health and shared pathways with berberine highlight therapeutic potential.
• Dysregulation contributes to metabolic stress and age-related diseases.
• Provides a target for small-molecule activators or inhibitors to modulate NAD+ levels.
Molecular Mechanism of ribosylnicotinamide kinase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs nicotinamide riboside and ATP, then transfers a phosphate from ATP to the sugar-like part of NR.
Ribosylnicotinamide kinase activity catalyzes the transfer of the gamma-phosphate of ATP to the 5'-hydroxyl group of beta-nicotinamide D-riboside, forming beta-nicotinamide D-ribonucleotide (NMN) and ADP. The reaction requires a divalent cation, typically Mg2+, which coordinates the phosphate groups of ATP. In bacteria, this activity resides in the C-terminal domain of the bifunctional NadR protein, which also acts as a transcriptional repressor. In mammals, the enzymes NRK1 and NRK2 share homology with the NadR kinase domain and perform the same phosphorylation.
Cofactors and Energetics
In simple terms: ATP provides the energy and phosphate group; the reaction releases energy as ADP and a proton.
ATP is the phosphate donor, and the reaction produces ADP and H+ as byproducts. The kinase activity is dependent on magnesium ions for neutralization of negative charges. The overall reaction is energetically favorable under physiological conditions, driving the salvage of NR toward NAD+ synthesis. The kinetic parameters of NRK1 for NR and ATP have been characterized, showing high affinity for NR in the low micromolar range.
Regulation of Enzyme Activity
In simple terms: The enzyme's activity can be turned up or down by cellular signals and feedback from NAD+ levels.
Ribosylnicotinamide kinase activity is regulated at multiple levels. In bacteria, NadR represses NAD biosynthetic genes in response to NAD+ and NMN levels, integrating kinase activity with transcription. In mammals, NRK1 expression is modulated by metabolic status and circadian rhythms, although direct allosteric regulation is less understood. NAD+ itself may feedback to inhibit upstream steps, but the exact mechanisms remain an active area of research. Additionally, the p38 MAPK pathway has been implicated in downstream effects of NR supplementation, suggesting crosstalk with stress signaling.
Evolutionary Conservation and Isoforms
In simple terms: The same basic enzyme design is found in bacteria and humans, but mammals have two versions, NRK1 and NRK2.
The ribosylnicotinamide kinase domain is conserved from bacteria to humans. In mammals, two isoforms exist: NRK1, which is widely expressed and considered the primary enzyme for NR phosphorylation, and NRK2, which is more tissue-restricted, notably in muscle. Both isoforms catalyze the same reaction but may differ in regulation and substrate specificity. The bacterial NadR protein combines this kinase activity with a DNA-binding repressor domain, illustrating a unique fusion of functions.
Key Genes Involved in GO:0050262 ribosylnicotinamide kinase activity
The following genes encode proteins that possess or regulate ribosylnicotinamide kinase activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NRK1 | Primary mammalian nicotinamide riboside kinase; phosphorylates NR to NMN | Central to NAD+ salvage; knockout reduces NAD+ levels and affects metabolism |
| NRK2 | Secondary mammalian NR kinase; tissue-specific expression | May compensate for NRK1 in muscle; less studied |
| NadR | Bifunctional bacterial protein with ribosylnicotinamide kinase and DNA-binding repressor domains | Model for understanding kinase regulation and NAD feedback |
| NAMPT | Catalyzes NMN to NAD+ in salvage pathway | Upstream of NRK1 in NAD+ synthesis; often co-studied |
| NMNAT1 | NMN adenylyltransferase, converts NMN to NAD+ | Downstream of NRK1; mutations cause retinal degeneration |
| NMNAT2 | NMN adenylyltransferase, neuronal isoform | Linked to axon degeneration; interacts with NAD+ salvage |
| NMNAT3 | Mitochondrial NMN adenylyltransferase | Mitochondrial NAD+ production; relevant to energy metabolism |
| CD38 | NAD+ glycohydrolase, consumes NAD+ | Modulates NAD+ levels; target for boosting NAD+ |
| PARP1 | NAD+-dependent DNA repair enzyme | Consumes NAD+; crosstalk with salvage pathway |
| SIRT1 | NAD+-dependent deacetylase | Mediates benefits of NAD+ supplementation |
| SIRT3 | Mitochondrial NAD+-dependent deacetylase | Regulates mitochondrial function; affected by NAD+ levels |
| cGAS | Cyclic GMP-AMP synthase, NAD+ sensor in inflammation | Linked to neuroinflammation in Alzheimer's models |
| STING | Stimulator of interferon genes, downstream of cGAS | Mediates senescence and inflammation; modulated by NAD+ |
| p38 MAPK | Stress-activated kinase | Involved in cytokine suppression by NR |
| NadR regulon genes | Bacterial NAD biosynthesis genes | Regulated by NadR repressor activity |
| NRK1 promoter | Regulatory region of NRK1 | Potential target for CRISPR activation/inhibition |
| NADSYN1 | NAD synthetase, final step of NAD+ synthesis | Integrates with salvage pathway |
| QPRT | Quinolinate phosphoribosyltransferase | De novo NAD+ pathway; cross-talk with salvage |
How Is ribosylnicotinamide kinase activity Regulated?
Ribosylnicotinamide kinase activity is regulated at the transcriptional and post-translational levels. In bacteria, the NadR protein represses NAD biosynthetic genes in response to NAD+ and NMN, directly linking kinase activity to gene expression. In mammals, NRK1 expression is influenced by metabolic cues such as fasting and circadian rhythms, though the precise mechanisms are still being elucidated. Additionally, the activity may be modulated by feedback inhibition from downstream metabolites like NAD+. The p38 MAPK pathway has been shown to mediate some effects of NR supplementation, suggesting that stress signaling can influence the pathway's output.
ribosylnicotinamide kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NRK1 | Ischemic brain injury; Alzheimer's disease | NRK1 knockout mice with NR supplementation |
| NRK1 | Myocardial infarction | Cardiac-specific NRK1 overexpression or knockout |
| NRK1 | Skin inflammation | Keratinocyte-specific knockout and NR treatment |
| NadR | Bacterial NAD homeostasis | NadR mutant bacteria for NAD biosynthesis studies |
| NRK2 | Muscle metabolism | Muscle-specific NRK2 knockout mice |
Neurodegeneration and Ischemic Brain Injury
Nicotinamide riboside, the substrate of ribosylnicotinamide kinase, has demonstrated neuroprotective effects in animal models. Acute treatment with nicotinamide riboside chloride reduced hippocampal damage and preserved cognitive function in mice with ischemic injury. In a transgenic Alzheimer's disease model, NAD+ supplementation via NR reduced neuroinflammation and cellular senescence through the cGAS-STING pathway. These benefits are dependent on the conversion of NR to NMN by NRK1, highlighting the importance of ribosylnicotinamide kinase activity in neuronal survival.
Cardiovascular Disease
In a mouse model of myocardial infarction, NR supplementation restored myocardial NAD+ levels, improved survival, and promoted a protective environment. The kinase activity of NRK1 is essential for these effects, as it catalyzes the rate-limiting step in NR utilization. This suggests that enhancing ribosylnicotinamide kinase activity could be a therapeutic strategy for ischemic heart disease.
Metabolic and Inflammatory Disorders
NAD+ decline is associated with metabolic stress and inflammation. NR supplementation has been shown to attenuate cytokine production in human keratinocytes via suppression of the p38 pathway, indicating a role for ribosylnicotinamide kinase activity in skin inflammation. Furthermore, mitochondrial health and shared pathways with berberine underscore the potential of targeting this activity in metabolic disorders. Dysregulation of NAD+ salvage is implicated in age-related metabolic decline.
From ribosylnicotinamide kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NRK1 knockout reduce NAD+ levels? | NRK1 knockout cell lines (e.g., HEK293) |
| Can a point mutation in NRK1 abolish kinase activity? | Point-mutation knock-in of catalytic residues |
| Does overexpression of NRK1 enhance NR-mediated NAD+ boost? | NRK1 overexpression stable cell lines |
| How does NadR regulate bacterial NAD genes? | NadR point mutants in E. coli |
| What is the effect of NRK1 knockout on neuronal survival? | Conditional NRK1 knockout mice |
| Can tagged NRK1 reveal subcellular localization? | Knock-in of fluorescent tag (e.g., GFP) |
How to Study the ribosylnicotinamide kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Kinase assay with radiolabeled ATP | Enzymatic activity of NRK1/NRK2 | Validation of purified enzyme or lysates |
| LC-MS metabolomics | Levels of NAD+, NMN, NR | Assessing pathway flux in cells/tissues |
| CRISPR knockout screen | Genes affecting NAD+ levels | Identifying novel regulators |
| Western blot | Protein expression of NRK1 | Confirming knockout or overexpression |
| Immunofluorescence | Subcellular localization of NRK1 | Determining organelle targeting |
| Mouse behavioral tests | Cognitive function after injury | Evaluating neuroprotection |
| Echocardiography | Cardiac function post-MI | Assessing NR therapy |
| Cytokine profiling | Inflammatory markers | Testing anti-inflammatory effects |
Enzymatic Assays for Kinase Activity
Direct measurement of ribosylnicotinamide kinase activity can be performed using radiolabeled ATP or by coupling the production of ADP to a luciferase-based detection system. High-performance liquid chromatography (HPLC) or mass spectrometry can quantify the conversion of NR to NMN. These assays are essential for validating the functional impact of mutations or inhibitors.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate ribosylnicotinamide kinase activity or NAD+ levels. For example, a screen for resistance to NAD+ depletion could reveal NRK1 as a top hit. Such screens are powerful for uncovering novel regulators and crosstalk with other pathways.
Metabolomics and NAD+ Quantification
Mass spectrometry-based metabolomics allows simultaneous quantification of NAD+, NMN, NR, and related metabolites in cells or tissues. This approach is critical for assessing the impact of genetic perturbations on the salvage pathway. Isotope tracing with labeled NR can track flux through ribosylnicotinamide kinase activity.
Animal Models and Phenotyping
Mouse models with tissue-specific knockout or overexpression of NRK1 are used to study the role of ribosylnicotinamide kinase activity in physiology and disease. Phenotypic readouts include cognitive tests, cardiac function, and inflammatory markers. These models bridge in vitro findings to whole-organism outcomes.
How CRISPR Can Be Used to Study GO:0050262 ribosylnicotinamide kinase activity
Knockout
CRISPR-Cas9 knockout of NRK1 or NRK2 can completely abolish ribosylnicotinamide kinase activity, leading to reduced NAD+ levels and impaired salvage of nicotinamide riboside. Such knockouts are valuable for studying the dependency of cells on this pathway and for identifying compensatory mechanisms. In bacteria, knockout of NadR affects both kinase activity and transcriptional regulation.
Point Mutation
Introducing point mutations in the catalytic domain of NRK1 (e.g., aspartate to alanine) can selectively eliminate kinase activity without affecting protein stability. This allows researchers to dissect the enzymatic function from other potential roles. Point mutations in NadR can separate its repressor and kinase functions.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) at the endogenous NRK1 locus enables visualization and immunoprecipitation of the enzyme at physiological expression levels. This approach is useful for studying localization, interaction partners, and dynamics. Knock-in of disease-associated mutations can model human conditions.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of NRK1 can boost ribosylnicotinamide kinase activity, increasing NAD+ levels and potentially protecting against metabolic stress. Overexpression models are instrumental for testing whether enhancing this activity is sufficient to produce therapeutic benefits in disease models.
How EDITGENE Supports ribosylnicotinamide kinase activity Research
Researchers studying ribosylnicotinamide kinase activity-related genes often need to determine whether a candidate gene is causally involved in NAD+ metabolism, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for ribosylnicotinamide kinase activity research.
Frequently Asked Questions About ribosylnicotinamide kinase activity
What is ribosylnicotinamide kinase activity?
It is the enzyme activity that phosphorylates nicotinamide riboside (NR) to nicotinamide mononucleotide (NMN), a key step in NAD+ salvage.
What genes are involved in ribosylnicotinamide kinase activity?
In mammals, NRK1 and NRK2 encode the kinases; in bacteria, the NadR gene encodes a bifunctional protein with this activity.
What is the reaction catalyzed by GO:0050262?
Beta-nicotinamide D-riboside + ATP = beta-nicotinamide D-ribonucleotide + ADP + H+.
How is ribosylnicotinamide kinase activity related to NAD+?
It produces NMN, which is directly converted to NAD+ by NMNAT enzymes, thus feeding the NAD+ salvage pathway.
What diseases are associated with ribosylnicotinamide kinase activity?
It has been implicated in ischemic brain injury, Alzheimer's disease, myocardial infarction, and inflammatory conditions.
Can CRISPR be used to study ribosylnicotinamide kinase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of NRK1/NRK2.
What is the role of NRK1 in NAD+ metabolism?
NRK1 is the primary enzyme that phosphorylates NR to NMN, controlling the rate of NAD+ salvage from NR.
How does NadR regulate bacterial NAD biosynthesis?
NadR combines ribosylnicotinamide kinase activity with a DNA-binding repressor domain that senses NAD+ and NMN to regulate gene expression.
What are the therapeutic implications of targeting this activity?
Enhancing ribosylnicotinamide kinase activity via NR supplementation has shown benefits in neurodegeneration and cardiovascular disease models.
What methods are used to measure ribosylnicotinamide kinase activity?
Enzymatic assays with radiolabeled ATP, LC-MS metabolomics, and CRISPR screens are commonly used.
Conclusion
Ribosylnicotinamide kinase activity (GO:0050262) is a fundamental enzymatic function in NAD+ salvage, catalyzing the conversion of nicotinamide riboside to nicotinamide mononucleotide. Its evolutionary conservation and critical role in cellular metabolism make it a focal point for research in aging, neurodegeneration, and cardiovascular disease. The availability of CRISPR-based models and advanced analytical methods now allows precise interrogation of this activity in health and disease. Continued exploration of ribosylnicotinamide kinase regulation and its crosstalk with other pathways holds promise for developing NAD+-boosting therapeutics.
References
- 1. Cheng YH et al.. 2022. Acute Treatment with Nicotinamide Riboside Chloride Reduces Hippocampal Damage and Preserves the Cognitive Function of Mice with Ischemic Injury.. Neurochem Res 47(8):2244-2253 PMID: 35585298
- 2. Hou Y et al.. 2021. NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING.. Proc Natl Acad Sci U S A 118(37) PMID: 34497121
- 3. Ratajczak J et al.. 2016. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.. Nat Commun 7:13103 PMID: 27725675
- 4. Tannous C et al.. 2024. Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction.. Cardiovasc Drugs Ther 38(6):1385-1396 PMID: 37999834
- 5. Visalli F et al.. 2026. Mitochondrial Health Through Nicotinamide Riboside and Berberine: Shared Pathways and Therapeutic Potential.. Int J Mol Sci 27(1) PMID: 41516357
- 6. Mao L et al.. 2025. c-di-GMP regulates bacterial NAD biosynthesis via targeting the transcriptional repressor NadR.. mBio 16(9):e0198225 PMID: 40823837
- 7. Xie C et al.. 2026. Nicotinamide mononucleotide and nicotinamide riboside attenuate cytokine production in human keratinocytes via suppression of p38 Pathway.. Mol Biol Rep 53(1) PMID: 41779073
- 8. Kurnasov OV et al.. 2002. Ribosylnicotinamide kinase domain of NadR protein: identification and implications in NAD biosynthesis.. J Bacteriol 184(24):6906-17 PMID: 12446641
